Quent Capital
TAK icon

Quent Capital’s Takeda Pharmaceutical TAK Stock Holding History

Quent Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.8K Buy
371
+262
+240% +$4.64K ﹤0.01% 1371
2026
Q2 		$1.75K Buy
+109
New +$1.8K ﹤0.01% 1490
2022
Q4 		– Sell
-20
Closed – – 1362
2022
Q3 		$0 Hold
20
– – ﹤0.01% 1277
2022
Q2 		$0 Hold
20
– – ﹤0.01% 1305
2022
Q1 		$0 Buy
+20
New +$294 ﹤0.01% 1323

Other funds holding TAK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Ethic Inc
Ethic Inc New York $8.7B AUM 37.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Hantz Financial Services
Hantz Financial Services Southfield, Michigan $7.48B AUM 14.09% 1-Year Est. Return

Quent Capital's TAK Position: Q3 2026 in Review

Quent Capital increased its Takeda Pharmaceutical (TAK) stake by 240% in Q3 2026, buying an estimated $4.64K and bringing the position to 371 shares worth $7.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1371.

Quent Capital first reported a position in TAK in Q1 2022 and has held it in 5 quarters since. 243 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Quent Capital held 371 shares of Takeda Pharmaceutical worth $7.8K as of Q3 2026.
  • Quent Capital bought 262 Takeda Pharmaceutical shares in Q3 2026, an estimated $4.64K.
  • Takeda Pharmaceutical made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #1371 holding.
  • Quent Capital first reported a position in Takeda Pharmaceutical in Q1 2022 and has held it in 5 quarters since.
  • 243 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.